Higher Serum Testosterone Levels Associated with Favorable Prognosis in Enzalutamide- and Abiraterone-Treated Castration-Resistant Prostate Cancer.
Sakamoto S, Maimaiti M, Xu M, Kamada S, Yamada Y, Kitoh H, Matsumoto H, Takeuchi N, Higuchi K, Uchida HA, Komiya A, Nagata M, Nakatsu H, Matsuyama H, Akakura K, Ichikawa T.
Sakamoto S, et al. Among authors: kitoh h.
J Clin Med. 2019 Apr 11;8(4):489. doi: 10.3390/jcm8040489.
J Clin Med. 2019.
PMID: 30978937
Free PMC article.